Skip to main content

Table 1 Characteristics of Patients Included in the Studies Evaluating Determinants of Home Death

From: The determinants of home and nursing home death: a systematic review and meta-analysis

Author, year, sample size, country

Patient population, age (years) male

Type of diseasea

Place of death

NOS quality assessment scaleb

Poulose et al. 2013 [13]

N = 842

Singapore

• Palliative home care team recipients

• ≥65: 475 (56 %)

• Male: 405 (48 %)

• Cancer: 729 (87 %)

• Non-cancer: 113 (13 %)

• Home: 241 (29 %)

• Hospital: 452 (54 %)

• Inpatient hospice: 149 (17 %)

• 7

Seow et al. 2014c [36]

N = 6,218

Canada

• Home care recipients

• Median (IQR): 75: (64–84)

• Male: 3,009 (48 %)

• Cancer: 4,950 (80 %)

• Non-cancer: 1,268 (20 %)

• Outside of hospital: 4,828 (78 %)

• Hospital: 1,390 (22 %)

• 7

Taylor et al. 2011 [17]

N = 1,268

New Zealand

• Hospice care recipients

• ≥55: 1,108 (88 %)

• Male: 603 (48 %)

• Cancer: 1,036 (82 %)

• Cardiovascular: 54 (4 %)

• Respiratory: 45 (4 %)

• Other: 120 (10 %)

• Home: 352 (28 %)

• Hospital : 675 (53 %)

• Nursing home: 203 (16 %)

• 7

Houttekier et al. 2011 [19]

N = 189,884

Belgium

• General end-of-life population

• ≥65: 54,311 (83 %)d

• Male: 32,718 (50 %)d

Cause of death

• Cancer: 18,321 (28 %)d

• Cardiovascular:16,813 (26 %)d

• Other: 30,100 (46 %)d

• Home: 14,726 (23 %)d

• Hospital: 33,856 (52 %) d

• Nursing home: 14,792 (23 %)d

• Other: 2,061 (3 %)d

• 6

Ikezaki et al. 2011 [21]

N = 4,175

Japan

• Receiving home care from nurses

• Mean: 84 ± 10e

• Male: 2,192 (53 %)

• Cancer: 1,664 (40 %)

• Cardiovascular: 504 (12 %)

• Pneumonia: 481 (12 %)

• Other: 1,509 (36 %)

• Home: 1,930 (46 %)

• Hospital: 2,245 (54 %)

• 7

Cardenas-Turanza et al. 2011 [22]

N = 473

Mexico

• General end-of-life population

• Mean (SD): 74 (73)

• Male: 235 (50 %)

Cause of death

• Cancer: 91 (19 %)

• Cardiovascular: 104 (22 %)

• Other: 278 (58 %)

• Home: 250 (53 %)

• Hospital: 223 (47 %)

• 8

Fukui et al. 2011 [23]

N = 568

Japan

• Receiving home palliative care from nurses

• Mean (SD): 73 (12)

• Male: 339 (60 %)

• Cancer: 100 %

• Home: 312 (55 %)

• Hospital: 256 (45 %)

• 8

Hong et al. 2011 [12]

N = 52,120

Singapore

• General end-of-life population

• ≥65: 33,938 (65 %)

• Male: 28,987 (56 %)

• Cancer: 100 %

• Home: 15,801 (30 %)

• Hospital: 27,592 (53 %)

• Inpatient Hospice: 5,592 (11 %)

• Other: 3,135 (6 %)

• 6

Houttekier et al. 2010 [20]

N = 1,690

Belgium

• General end-of-life population

• ≥65: 1,462 (88 %)

• Male: 839 (50 %)

Cause of death

• Cancer: 725 (43 %)

• Cardiovascular: 237 (14 %)

• Other: 728 (43 %)

• Home: 402 (24 %)

• Hospital: 664 (39 %)

• Nursing home: 451 (27 %)

• Palliative care unit: 171 (10 %)

• 7

Houttekier et al. 2010 [18]

N = 237,579f

Netherlands/England

• General end-of-life population

• ≥70: 131,574 (73 %)

• Male: 90,619 (50 %)

Cause of death

• Cancer: 170,339 (72 %)

• Heart failure: 11,599 (7 %)

• Other: 52,454 (22 %)

• Home: 49,036 (21 %)

• Hospital: 114,401 (48 %)

• Nursing home: 39,256 (17 %)

• Other: 34,886 (14 %)

• 6

Tang et al. 2010 [25]

N = 201,252

Taiwan

• General end-of-life population

• ≥65: 119,690 (59 %)

• Male: 129,354 (64 %)

• Cancer: 100 %

• Home: 68,139 (34 %)

• Hospital: 133,113 (66 %)

• 7

Hayashi et al. 2011 [26]

N = 99

Japan

• Home care service recipients

• Mean (SD): 78 (13)

• Male: 49 (50 %)

• Cancer: 38 (38 %)

• Ischemic heart disease: 19 (19 %)

• Other: 42 (42 %)

• Home: 40 (40 %)

• Hospital: 59 (60 %)

• 5

Bell et al. 2009 [27]

N = 1,352

United States

• General end-of-life population

• Mean: 84

• Male: 100 %

Cause of death

• Cancer: 337 (25 %)

• Coronary: 181 (13 %)

• Other: 834 (62 %)

• Home: 306 (23 %)

• Hospital: 800 (59 %)

• Nursing home: 246 (18 %)

• 5

Lin et al. 2007 [29]

N = 697,814

Taiwan

• General end-of-life population

• ≥75: 423,552 (61 %)

• Male: 290,394 (42 %)

• Cancer: 143,529 (21 %)

• Circulatory: 185,679 (27 %)

• Respiratory: 85,763 (12 %)

• Other: 279,126 (40 %)

• Home; 459,005 (66 %)

• Hospital: 238,809 (34 %)

• 7

Gruneir et al. 2007 [30]

N = 1,402,167

United States

• General end-of-life population

• ≥75: 810,453 (58 %)

• Male: 671,638 (48 %)

Cause of death

• Cancer: 351,944 (25 %)

• Cardiovascular: 427,661 (31 %)

• Other: 623,964 (44 %)

• Home: 330,447 (24 %)

• Hospital: 740,405 (53 %)

• Nursing home: 331,315 (24 %)

• 7

Motiwala et al. 2006 [32]

N = 58,689

Canada

• General end-of-life population

• ≥75: 43,071 (73 %)

• Male: 27,749 (47 %)

• Cancer: 19,966 (34 %)

• Dementia: 16,267 (28 %)

• Other: 22,302 (38 %)

Not available

• 8

Cohen et al. 2006 [33]

N = 55,759

Belgium

• General end-of-life population

• ≥65: 46,271 (83 %)

• Male: 28,248 (51 %)

Cause of death

• Cancer: 15,008 (27 %)

• Cardiovascular: 15,846 (28 %)

• Other: 27,793 (45 %)

• Home: 13,549 (24 %)

• Hospital: 29,943 (54 %)

• Nursing home: 11,041 (20 %)

• Other: 1,115 (2 %)

• 6

Brazil et al. 2005 [2]

N = 214

Canada

• Home palliative care recipients

• ≥50 year: 100 %

• Male: 142 (66 %)

• Cancer: 207 (96 %)

• Non-cancer: 7 (4 %)

• Home: 120 (56 %)

• Institution: 94 (44 %)

• 8

Klinkenberg et al. 2005 [34]

N = 270

Netherlands

• General end-of-life population

• ≥80: 168 (62 %)

• Male: 167 (62 %)

Cause of death

• Cancer: 65 (24 %)

• Non-cancer: 201 (76 %)

• Home: 135 (50 %)

• Hospital: 86 (32 %)

• Nursing home: 46 (17 %)

• 7

Aabom et al. 2005 [35]

N = 4,386

Denmark

• Home residents

• >65: 2,979 (68 %)

• Male: 2,145 (49 %)

• Cancer: 100 %

• Home: 1,221 (28 %)

• Hospital: 2,412 (55 %)

• Nursing home: 702 (16 %)

• 7

Fukui et al. 2004 [24]

N = 428

Japan

• Home care recipients

• Mean (SD): 75 (11)

• Male: 247 (58 %)

• Cancer: 100 %

• Home: 285 (67 %)

• Hospital: 143 (33 %)

• 7

  1. Abbreviations: IQR inter-quartile range, NOS Newcastle-Ottawa Scale, SD standard deviation
  2. aCause of death was used for some of the studies (as specified), if this information was reported instead of type of disease
  3. bAdditional details in Additional file 4
  4. cThe study was originally included based on data from a 2013 conference abstract, however, the results of its subsequent publication in the peer-reviewed literature in 2014 was incorporated in our analyses. [36]
  5. d2007 data shown (N = 65,435)
  6. enon-cancer patients data shown (N = 2,511)
  7. fData for England and Netherlands used in our analysis as the data for Belgium may be a duplicate of another publication already included in the analysis [19]. Results for England are shown on this table